Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
6.37
-0.23 (-3.48%)
At close: Aug 11, 2026, 4:00 PM EDT
6.30
-0.07 (-1.10%)
Pre-market: Aug 12, 2026, 4:01 AM EDT
Nuvation Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 258.6 | 164.09 | 35.72 | 42.65 | 101.1 | 132.42 |
Short-Term Investments | 402.35 | 365.13 | 466.97 | 568.56 | 559.92 | 632.97 |
Cash & Short-Term Investments | 660.96 | 529.21 | 502.69 | 611.21 | 661.01 | 765.39 |
Cash Growth | 8.76% | 5.27% | -17.76% | -7.53% | -13.64% | 254.76% |
Accounts Receivable | 27.83 | 16.08 | 12.72 | - | - | - |
Other Receivables | 3.89 | 3.29 | 3.57 | 3.7 | 2.49 | 3.04 |
Total Trade Receivables | 31.71 | 19.36 | 16.29 | 3.7 | 2.49 | 3.04 |
Inventory | 19.9 | 11.41 | - | - | - | - |
Other Current Assets | 13.86 | 11.54 | 7.27 | 1.52 | 3.82 | 3.64 |
Total Current Assets | 726.43 | 571.52 | 526.26 | 616.43 | 667.32 | 772.07 |
Net Property, Plant & Equipment | 3.96 | 4.48 | 2.99 | 4.32 | 4.69 | 3.66 |
Other Intangible Assets | 10.29 | 11.21 | 4.62 | - | - | - |
Other Long-Term Assets | 3.82 | 7.61 | 6.76 | 0.73 | 0.14 | 0.42 |
Total Assets | 744.5 | 594.82 | 540.63 | 621.48 | 672.14 | 776.15 |
Accounts Payable | 12.09 | 9.48 | 6.35 | 2.21 | 2.14 | 3.93 |
Accrued Expenses | 45.2 | 45.18 | 32.83 | 9.79 | 9.82 | 12.14 |
Short-Term Debt | 5.89 | 5.72 | 6.28 | - | - | - |
Current Portion of Leases | 1.72 | 1.88 | 1.66 | 1.97 | 1.21 | 0.86 |
Unearned Revenue | 8.86 | 7.52 | 11.12 | - | - | - |
Other Current Liabilities | 13 | 12.45 | - | - | - | - |
Total Current Liabilities | 86.76 | 82.23 | 58.24 | 13.97 | 13.16 | 16.93 |
Long-Term Debt | 393.75 | 193.03 | - | - | - | - |
Long-Term Leases | 1.91 | 2.54 | 0.97 | 2.04 | 3.05 | 2.19 |
Other Long-Term Liabilities | 8.23 | 11.31 | 17.63 | 0.35 | 0.85 | 11.04 |
Total Long-Term Liabilities | 403.88 | 206.88 | 18.59 | 2.39 | 3.9 | 13.23 |
Total Liabilities | 490.64 | 289.11 | 76.84 | 16.36 | 17.07 | 30.15 |
Accumulated Other Comprehensive Income | -2.61 | -0.19 | 0.57 | 0.18 | -5.53 | -1.19 |
Retained Earnings | -1,173 | -1,115 | -910.74 | -342.8 | -267 | -162.8 |
Total Common Shareholders' Equity | -1,175 | -1,116 | -910.17 | -342.62 | -272.53 | -163.99 |
Shareholders' Equity | 253.86 | 305.72 | 463.79 | 605.12 | 655.08 | 746 |
Total Liabilities & Equity | 744.5 | 594.82 | 540.63 | 621.48 | 672.14 | 776.15 |
Total Debt | 403.26 | 203.17 | 8.92 | 4.01 | 4.26 | 3.06 |
Net Cash (Debt) | 257.69 | 326.04 | 493.78 | 607.21 | 656.75 | 762.34 |
Net Cash Growth | -36.71% | -33.97% | -18.68% | -7.54% | -13.85% | 253.60% |
Net Cash Per Share | 0.73 | 0.95 | 1.84 | 2.77 | 3.03 | 3.85 |
Book Value | -1,175 | -1,116 | -910.17 | -342.62 | -272.53 | -163.99 |
Book Value Per Share | -3.33 | -3.27 | -3.39 | -1.57 | -1.26 | -0.83 |
Tangible Book Value | -1,186 | -1,127 | -914.79 | -342.62 | -272.53 | -163.99 |
Tangible Book Value Per Share | -3.36 | -3.30 | -3.40 | -1.57 | -1.26 | -0.83 |